Patents by Inventor Tiziano Alighieri

Tiziano Alighieri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL FORMULATIONS FOR THE ORAL ADMINISTRATION OF PPI
    Publication number: 20110045068
    Abstract: The present invention relates to pharmaceutical formulations comprising a layer of compressed granules to facilitate the administration of oral PPI.
    Type: Application
    Filed: November 7, 2008
    Publication date: February 24, 2011
    Inventors: Roberto Valducci, Tiziano Alighieri, Serozh Avanessian
  • Controlled Release Pharmaceutical Composition of Venlafaxine Hydrochloride, and Process for Preparation Thereof
    Publication number: 20090263471
    Abstract: Herein is described a controlled release pharmaceutical composition of venlafaxine hydrochloride, an effective antidepressant, comprising an inert core; on which the active principle is uniformly layered, that in turn is coated with a layer comprising a hardening agent and a lipophilic agent; the process for the preparation of said pharmaceutical composition is also described.
    Type: Application
    Filed: September 29, 2006
    Publication date: October 22, 2009
    Inventors: Roberto Valducci, Tiziano Alighieri, Serozh Avanessian
  • Modified Release Formulation of Lithium Carbonate and Method for Preparation Thereof
    Publication number: 20070148253
    Abstract: Modified release formulation of lithium carbonate in microgranules or similar comprising, for around 300 Kg of Lithium Carbonate, at least: Overall Povidone in quantity between 8.0 Kg and 40.0 Kg; Ethylcellulose in quantity between Kg 0.9 and Kg 3.6.
    Type: Application
    Filed: December 19, 2006
    Publication date: June 28, 2007
    Applicant: Valpharma International S.P.A.
    Inventors: Roberto Valducci, Tiziano Alighieri, Serozh Avanessian
  • Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
    Publication number: 20060039997
    Abstract: This invention refers to: multiparticulate formulations of Lithium salts for oral administration constituted by either modified release granules or mixtures of modified and conventional release granules, suitable for once-a-day administration also at high strengths of Lithium salts, and to the preparation process of said formulations.
    Type: Application
    Filed: October 14, 2005
    Publication date: February 23, 2006
    Applicant: VAL PHARMA S.A.
    Inventors: Roberto Valducci, Tiziano Alighieri, Serozh Avanessian
  • Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
    Patent number: 6994873
    Abstract: This invention refers to: multiparticulate formulations of Lithium salts for oral administration constituted by either modified release granules or mixtures of modified and conventional release granules, suitable for once-a-day administration also at high strengths of Lithium salts, and to the preparation process of said formulations.
    Type: Grant
    Filed: February 4, 2002
    Date of Patent: February 7, 2006
    Assignee: Valpharma S.A.
    Inventors: Roberto Valducci, Tiziano Alighieri, Serozh Avanessian
  • Multiparticulate enteric coated and multiparticulate enteric coated prolonged release formulations containing NADH
    Publication number: 20030181414
    Abstract: Formulations for the oral administration of NADH in multiparticulate enteric coated form and/or dosed either into gelatine capsules or sachets or dispensers
    Type: Application
    Filed: March 12, 2003
    Publication date: September 25, 2003
    Applicant: VALPHARMA S.A.
    Inventors: Roberto Valducci, Tiziano Alighieri, Serozh Avanessian
  • Modified release pharmaceutical composition containing bupropion HCI as active substance
    Publication number: 20030134906
    Abstract: Pharmaceutical composition in modified release tablet form containing Bupropion HCl as active substance and including, at the same time, hydrophilic components and hydrophobic ingredients mixed with an excipient substance.
    Type: Application
    Filed: May 31, 2002
    Publication date: July 17, 2003
    Applicant: VALPHARMA S.A.
    Inventors: Roberto Valducci, Tiziano Alighieri, Serozh Avanessian